(Q44854309)

6 December 2017

0 references

1 reference

title

HIV co-receptor identification: good or bad news for drug discovery? (English)

1 reference

6 December 2017

1 reference

Landau NR

1

1 reference

6 December 2017

publication date

1 October 1997

1 reference

Current Opinion in Immunology

6 December 2017

published in

1 reference

6 December 2017

volume

9

1 reference

6 December 2017

issue

5

1 reference

6 December 2017

page(s)

628-630

1 reference

Co-receptors for HIV-1 entry

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980040-4

7 January 2021

Expression cloning of new receptors used by simian and human immunodeficiency viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980040-4

7 January 2021

Protease inhibitors in patients with HIV disease. Clinically important pharmacokinetic considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980040-4

7 January 2021

Contrasting Genetic Influence of CCR2 and CCR5 Variants on HIV-1 Infection and Disease Progression

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980040-4

7 January 2021

The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980040-4

7 January 2021

Heterozygosity for a deletion in the CKR-5 gene leads to prolonged AIDS-free survival and slower CD4 T-cell decline in a cohort of HIV-seropositive individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980040-4

7 January 2021

Change in coreceptor use correlates with disease progression in HIV-1--infected individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980040-4

7 January 2021

Two antigenically distinct subtypes of human immunodeficiency virus type 1: viral genotype predicts neutralization serotype

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980040-4

7 January 2021

Mechanisms contributing to the neutralization of HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980040-4

7 January 2021

High concentrations of recombinant soluble CD4 are required to neutralize primary human immunodeficiency virus type 1 isolates

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980040-4

7 January 2021

10.1016/S0952-7915(97)80040-4

Identifiers

DOI

1 reference

6 December 2017

1 reference